Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.60    -0.05 (-1.89%)
Bid:
2.65
Ask:
2.70
Spread: 0.05 (1.887%)
Market Cap: £4.74m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Lighting Division Update

27 Nov 2015 07:00

RNS Number : 1436H
Nanoco Group PLC
27 November 2015
 



 

For immediate release

27 November 2015

 

RNS REACH

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Lighting Division Update

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces the following update on its Lighting Division following the successful launch of the world's first CFQD® Quantum Dot lighting products at the LuxLive industry trade show in London.

 

Nanoco and its partner Marl International, a UK-based pioneer in LED lighting, launched four product groups at LuxLive including light-emitting ceiling tiles, strip lights, down lighters, and grow lights. All of the product groups use Nanoco CFQD® Quantum Dot film, with the thickness of the film and the size of the quantum dots fine-tuned for specific end uses where colour quality is the primary requirement.

 

In the run up to last week's LuxLive trade show, Nanoco was highlighted in the Lux Global Hotlist 2015 of the ten most exciting lighting firms worldwide. The Global Hotlist panel's citation described Nanoco as a producer of "cadmium-free quantum dots which promise near perfect colour rendering from LEDs". In addition, the Orion strip light developed with Marl was listed among the "10 product innovations to look out for" at the LuxLive show.

 

These accolades contributed to a high level of interest in Nanoco and Marl's stand at the show, along with a number of potential new business opportunities.

 

The lighting products for ambient and specialty lighting displayed at the show included light-emitting ceiling tiles that create diffuse, artificial daylight with a colour temperature of 6500k and low power consumption. These tiles have outstanding colour performance and are ideally suited to high end retail, healthcare and commercial applications.

 

The CFQD® Quantum Dot strip lights shown at LuxLive are particularly suited to architectural lighting applications and the down lights offer high end retailers the opportunity to showcase their merchandise under perfect lighting conditions.

 

Two versions of Nanoco and Marl's grow lights for horticultural applications were also showcased at LuxLive. These grow lights benefit from cadmium-free quantum dots tuned to the wavelengths of light needed for plant growth, hence saving energy and creating optimum lighting conditions. Nanoco is continuing to develop this grow light technology, for example by creating quantum dot films for specific types of plants.

 

Michael Edelman, Nanoco's CEO, commented: "We were delighted by the level of interest at LuxLive in the use of our cadmium-free quantum dot technology in lighting applications. We were also excited by the interest in the range of products that we have created alongside our partner Marl International.

 

"LEDs were by far the dominant lighting type at LuxLive, reflecting the compelling attractions of LEDs in the future of lighting. Our technology has the ability to add outstanding colour performance to the other benefits of LEDs, particularly energy efficiency."

 

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

David Blain, Chief Financial Officer

Caroline Watson, Investor Relations Manager

cwatson@nanocotechnologies.com

 

Tel: + 44 (0) 7799 897357

Canaccord Genuity - Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Mark Whitmore

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Neil Patel

Richard Bootle

Steven Tredget

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocotechnologies.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABFBBTMBATTMA
Date   Source Headline
20th Apr 20177:00 amRNSDirectorate Change
4th Apr 20176:22 pmRNSHolding(s) in Company
4th Apr 201712:00 pmRNSHolding(s) in Company
4th Apr 20177:00 amRNSInterim Results
30th Mar 20177:00 amRNSWebcast of Interim Results
6th Mar 20177:00 amRNSNotice of Results
8th Feb 20179:42 amRNSHolding(s) in Company
6th Feb 20177:00 amRNSNotification of Major Interest in Shares
3rd Feb 20179:57 amRNSNotification of Major Interest in Shares
27th Jan 20177:00 amRNSDirectorate Change
19th Jan 201710:55 amRNSBlock Listing Six Monthly Return
16th Jan 20175:00 pmRNSNotification of Major Interest in Shares
6th Jan 20177:00 amRNSNanoco to Present at Needham Growth Conference
4th Jan 20177:00 amRNSNanoco Fine Color Film TVs at CES
3rd Jan 201712:10 pmRNSNotification of Major Interest in Shares
28th Dec 20163:39 pmRNSNotification of Major Interest in Shares
22nd Dec 20163:55 pmRNSDirector/PDMR Shareholding
22nd Dec 20167:00 amRNSNotification of Major Interest in Shares
20th Dec 20164:13 pmRNSNotification of Major Interest in Shares
19th Dec 20165:38 pmRNSNotification of Major Interest in Shares
15th Dec 20164:15 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
12th Dec 20167:00 amRNSNotification of Major Interest in Shares
9th Dec 20163:00 pmRNSNotification of Major Interest in Shares
6th Dec 20168:55 amRNSNotification of Major Interest in Shares
2nd Dec 20162:25 pmRNSNotification of Major Interest In Shares
28th Nov 20167:00 amRNSAcquires Quantum Dot Patents from Kodak
23rd Nov 20167:00 amRNSNotification of Transactions by Directors/PDMRs
17th Nov 20163:22 pmRNSNotification of Major Interest in Shares
7th Nov 20166:26 pmRNSTR-1 NOTIFICATION OF MAJOR INTEREST IN SHARES
3rd Nov 20167:00 amRNSAnnual Report & Accounts 2016
17th Oct 20163:15 pmRNSDirector Share Purchase
17th Oct 20161:00 pmRNSNotification of Major Interest in Shares
14th Oct 201612:45 pmRNSDirector Share Purchase
13th Oct 20162:55 pmRNSDirector Share Purchase
13th Oct 20162:43 pmRNSNotification of Major Interest in Shares
11th Oct 20167:00 amRNSPreliminary Results
7th Oct 20167:00 amRNSUpdate re Unaudited Revenues
4th Oct 20167:00 amRNSWebcast of Preliminary Results
20th Sep 20167:00 amRNSNotification of Preliminary Results
8th Sep 20161:05 pmRNSNotification of major interest in shares
31st Aug 201611:29 amRNSNotification of Major Interest in Shares
31st Aug 20167:00 amRNSTotal Voting Rights
30th Aug 20163:05 pmRNSBlock Listing Six Monthly Return
18th Aug 20165:55 pmRNSNotification of Major Interest in Shares
17th Aug 201612:35 pmRNSNotification of Major Interest in Shares
17th Aug 20167:00 amRNSChange of Adviser
10th Aug 201612:50 pmRNSNotification of Major Interest in Shares
8th Aug 20167:00 amRNSNanoco to present at Canaccord Conference
8th Aug 20167:00 amRNSFull Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.